Valuation Actuate Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 11:39:24 2026-07-13 EDT			5-day change	1st Jan Change
1.480 ^USD	+22.31%		+9.29%	-75.00%

06-29	Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index	CI
06-29	Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	155.5	142.2	28.95	-	-
Change	-	-8.5%	-79.65%	-	-
Enterprise Value (EV)	155.5	142.2	28.95	28.95	28.95
Change	-	-8.5%	-79.65%	0%	0%
P/E	-	-	-	-	-
PBR	-	-	-	-	-
PEG	-	-	-	-	-
Capitalization / Revenue	-	-	-	-	-
EV / Revenue	-	-	-	-	-
EV / EBITDA	-	-	-	-	-
EV / EBIT	-0x	-0x	-1.26x	-0.94x	-0.79x
EV / FCF	-	-0x	-1.38x	-0.85x	-0.69x
FCF Yield	-	-15.6%	-72.5%	-118%	-144%
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales ¹	-	-	-	-	-
EBITDA	-	-	-	-	-
EBIT ¹	-25.16	-22.5	-23.02	-30.95	-36.78
Net income	-	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	7.960	6.120	1.210	1.210	1.210
Nbr of stocks (in thousands)	19,532	23,243	23,926	-	-
Announcement Date	3/13/25	3/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ACTUATE THERAPEUTICS, INC.	-	-	-	-	28.95M
WUXI APPTEC CO., LTD.	20.57x	6.33x	13.8x	1.56%	54.88B
ARGENX SE	32.72x	8.29x	25.68x	0.06%	54.63B
INSMED INCORPORATED	-44.31x	14.51x	-42.32x	-.--%	25.06B
BIONTECH SE	-18.2x	4.33x	-7.58x	-.--%	23.14B
WUXI BIOLOGICS (CAYMAN) INC.	25x	4.9x	12.9x	-.--%	19.87B
GENMAB A/S	24.48x	4.79x	15.58x	-.--%	17.55B
PHARMAESSENTIA CORPORATION	49.34x	20.07x	51.69x	0.07%	16.5B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-539.24x	37.99x	-4235.53x	-.--%	15.75B
EXELIXIS, INC.	17.75x	5.16x	12.01x	-.--%	14.2B
Average	-47.99x	11.82x	-461.53x	0.19%	24.16B
Weighted average by Cap.	-21.17x	10.13x	-265.84x	0.37%